TG-100435 is a multitargeted, orally active protein tyrosine kinase inhibitor, with K i of 13 to 64 nM for Src , Lyn , Abl , Yes , Lck , and EphB4 . TG-100435 plays an important role in cancer research.
Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Src | Products > Signaling Pathways > Bcr-Abl | Products > Signaling Pathways > Ephrin Receptor
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。